Searching for the Spectral Signature of Alzheimer’s
Could a tri-spectral retinal imaging module offer new hopes for Alzheimer’s disease screening?
Objective:
To develop a practical screening tool for Alzheimer's disease (AD) using label-free tri-spectral retinal imaging.
Key Findings:
- AD eyes showed increased blue reflectance compared to controls in the B/G ratiometric map.
- The machine learning model achieved an AUC of 0.83 in cross-validation and 0.91 in an independent test set.
Interpretation:
Tri-spectral imaging provides a non-invasive, scalable method for AD screening that integrates into existing ophthalmic workflows.
Limitations:
- The study is limited by its small sample size.
- Further validation with larger datasets is necessary before clinical application.
Conclusion:
Tri-spectral imaging holds promise for AD screening but requires more extensive research for clinical implementation.
